![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 11, 2021 10:05:06 AM
"New drug against corona: Lenzilumab
May 11, 2021
https://www.finansgundem.com/haber/koronaya-karsi-yeni-ilac-lenzilumab/1570464
Humanigen's lenzilumab monoclonal antibody works wonders against Covid-19
11 MAY 2021
https://translate.google.com/translate?sl=auto&tl=en&u=https://kourdistoportocali.com/news-desk/to-farmako-monokloniko-antisoma-lenzilumab-tis-etaireias-humanigen-kanei-thaymata-kata-tis-covid-19/
At least this article references Reuters as the source.
If you are saying that Durrant's outlook has perhaps improved between the time of his comments when the topline data was released on March 29th, and the time of the full data readout, I certainly hope you are right. But an improved outlook is certainly what I am looking for, and have not yet seen.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM